Who has invested in Bryn Pharma?

Chazen Capital Partners are named among the investors backing Bryn Pharma.

Bryn Pharma Funding: $128M Raised, Series C (2019)

Bryn Pharma funding overview

Bryn Pharma is a Biotech company based in Raleigh, C.C.. Bryn Pharma has raised $128M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in October 2019. The round record for Bryn Pharma runs through 2019; nothing later has been disclosed. Investors on record include Chazen Capital Partners.

Bryn Pharma at a glance

Total raised: $128M
Latest round: Series C
Latest round date: October 2019
Industry: Biotech
Headquarters: Raleigh, C.C.
Notable investors: Chazen Capital Partners

Frequently asked about Bryn Pharma funding

How much has Bryn Pharma raised?: Bryn Pharma has raised $128M in total disclosed funding across the rounds on record.
Who has invested in Bryn Pharma?: Chazen Capital Partners are named among the investors backing Bryn Pharma.
What was the latest Bryn Pharma funding round?: The most recent disclosed round is a Series C, announced in October 2019.
Where is Bryn Pharma based?: Bryn Pharma is based in Raleigh, C.C..
What sector does Bryn Pharma operate in?: Bryn Pharma is tracked under Biotech from Raleigh, C.C., with $128M in disclosed funding.
When did Bryn Pharma last raise?: The last disclosed Bryn Pharma round closed in October 2019 at Series C.

Bryn Pharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Raleigh below to benchmark round size and investor mix.

Bryn Pharma Funding: $128M Raised, Series C (2019)

Bryn Pharma funding overview

Bryn Pharma at a glance

Frequently asked about Bryn Pharma funding

Companies related to Bryn Pharma (36)

Browse related funding lists (3)